We are live on ! Find out more
LYFE

2ndVote Life Neutral Plus ETF

Delisted

LYFE was delisted on the 3rd of August, 2023.

7 hedge funds and large institutions have $1.1M invested in 2ndVote Life Neutral Plus ETF in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $917K → $1.1M (+$185K)

13% less funds holding

Funds holding: 87 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

LYFE Hedge Fund Activity: Q3 2022 in Review

7 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in 2ndVote Life Neutral Plus ETF (LYFE) for Q3 2022, worth a combined $1.1M — up 20% from $917K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of LYFE and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, adding an estimated $220K. The largest seller was Steward Financial Group, exiting entirely with an estimated $45K sold.

  • 7 institutional investors held 2ndVote Life Neutral Plus ETF (LYFE) as of Q3 2022, down from 8 in Q2 2022.
  • Funds reported $1.1M of 2ndVote Life Neutral Plus ETF stock for Q3 2022, up 20% quarter-over-quarter.
  • 1 fund opened new 2ndVote Life Neutral Plus ETF positions in Q3 2022 and 2 closed out, a net change of -1 holder.
  • The largest 2ndVote Life Neutral Plus ETF buyer in Q3 2022 was Citadel Advisors, an estimated $220K added.
  • The largest 2ndVote Life Neutral Plus ETF seller in Q3 2022 was Steward Financial Group, an estimated $45K sold.

Based on aggregated 13F filings for Q3 2022.